Literature DB >> 9094047

Cerebrospinal fluid carnitine levels in patients with Parkinson's disease.

F J Jiménez-Jiménez1, J C Rubio, J A Molina, M A Martín, Y Campos, J Benito-León, M Ortí-Pareja, T Gasalla, J Arenas.   

Abstract

We assessed free carnitine (FC) and acyl-carnitine esters (AC) in both CSF and plasma from 29 patients with diagnostic criteria for PD, and from 29 healthy matched-controls. FC and AC levels in both CSF and plasma did not differ significantly between PD patients and controls, they were not influenced significantly by anti-parkinsonian drugs, and did not correlate with age at onset, duration and severity of PD. These results suggest that CSF carnitine levels are apparently unrelated with the risk for PD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094047     DOI: 10.1016/s0022-510x(96)00259-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques.

Authors:  William R Wikoff; Gurudutt Pendyala; Gary Siuzdak; Howard S Fox
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

2.  Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update.

Authors:  Rupasri Mandal; An Chi Guo; Kruti K Chaudhary; Philip Liu; Faizath S Yallou; Edison Dong; Farid Aziat; David S Wishart
Journal:  Genome Med       Date:  2012-04-30       Impact factor: 11.117

Review 3.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

Review 4.  The Role of Lipids in Parkinson's Disease.

Authors:  Helena Xicoy; Bé Wieringa; Gerard J M Martens
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

5.  Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson's disease.

Authors:  Pedro A B Pereira; Drupad K Trivedi; Justin Silverman; Ilhan Cem Duru; Lars Paulin; Petri Auvinen; Filip Scheperjans
Journal:  NPJ Parkinsons Dis       Date:  2022-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.